NW Angel Fund: Investment Portfolio & Startup News

AI Search

Announce News

NW Angel Fund

To add a bio or update investment portfolio click update information.

Investment Portfolio

Combat Medical

12 Mar 2026

Combat Medical raises a £2.6m Series A led by T&J Meyer Family Foundation for hard-to-treat bladder cancer

Combat Medical develops medical devices designed to optimise the delivery and effectiveness of cancer therapeutics. Its HIVEC treatment delivers hyperthermic intravesical chemotherapy to treat bladder cancer and improve chemotherapy efficacy and tolerability.

NW Angel Fund

- Health
1(12 months)
nwangel.com

More venture news

FluoRok
5 Nov 2026
FluoRok closes a £22m Series A round led by Orano and Supernova to manufacture safer fluorochemicals for lithium-ion batteries
Series AIndustrial
Alethio Therapeutics
5 Nov 2026
Alethio Therapeutics secures a £67m Series A round led by Sofinnova Partners and RA Capital to develop targeted blood cancer therapies
Series ALife Sciences
LO:TECH
2 Nov 2026
LO:TECH secures a £9m Series A round led by MMC to build a 24/7 trading firm for traditional, digital and onchain markets
Series AFintech

NW Angel Fund: Investment Portfolio & Startup News

Investment Portfolio

Combat Medical raises a £2.6m Series A led by T&J Meyer Family Foundation for hard-to-treat bladder cancer

More venture news

FluoRok closes a £22m Series A round led by Orano and Supernova to manufacture safer fluorochemicals for lithium-ion batteries

Alethio Therapeutics secures a £67m Series A round led by Sofinnova Partners and RA Capital to develop targeted blood cancer therapies

LO:TECH secures a £9m Series A round led by MMC to build a 24/7 trading firm for traditional, digital and onchain markets